Ticker > Company >

Anlon Healthcare share price

Anlon Healthcare Ltd.

  27.38 K   5   0 NSE: AHCL BSE: 544497 SECTOR: Pharmaceuticals & Drugs

15.61
+0.13 (0.84%)
NSE: 08 Sep 4:00 PM

Price Summary

Today's High

₹ 15.69

Today's Low

₹ 15.41

52 Week High

₹ 17.28

52 Week Low

₹ 10.2

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

829.69 Cr.

Enterprise Value

871.88 Cr.

No. of Shares

53.15 Cr.

P/E

28.55

P/B

3.1

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  5.04

CASH

3.41 Cr.

DEBT

45.6 Cr.

Promoter Holding

52.68 %

EPS (TTM)

₹  0.55

Sales Growth

46.73%

ROE

19.17 %

ROCE

22.38%

Profit Growth

35.53 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year46.73%
3 Year16.07%
5 YearNA

Profit Growth

1 Year35.53%
3 Year68.43%
5 YearNA

ROE%

1 Year19.17%
3 Year42.54%
5 Year50.21%

ROCE %

1 Year22.38%
3 Year20.9%
5 Year16.91%

Debt/Equity

0.2174

Price to Cash Flow

-17.9

Interest Cover Ratio

10.3445

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 52.68 0.00
Mar 2026 52.68 0.00
Dec 2025 52.68 0.00
Sep 2025 52.68 0.00
Jun 2025 52.68 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 68.4289073320017% for the Past 3 years.
  • The company has shown a good revenue growth of 16.0675607235777% for the Past 3 years.
  • The company has significantly decreased its debt by 20.9551 Cr.
  • Company has been maintaining healthy ROE of 42.5359% over the past 3 years.
  • Company has been maintaining healthy ROCE of 20.8970666666667% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 10.3445.
  • Company has a healthy liquidity position with current ratio of 2.5739.
  • The company has a high promoter holding of 52.68%.

 Limitations

  • Company has high debtor days of 185.2622.
  • Company has negative cash flow from operations of -46.3581.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 33.3 52.2 35.58 55.42 30.98
Total Expenditure 27.06 38.46 23.24 41.51 23.51
Operating Profit 6.24 13.74 12.34 13.91 7.47
Other Income 0.01 0.03 0.2 0.01 0.06
Interest 0.82 0.87 1.58 1.18 0.96
Depreciation 0.43 0.45 0.35 0.13 0.66
Exceptional Items 0 0 0 0 0
Profit Before Tax 5 12.45 10.62 12.61 5.9
Tax 1.46 3.13 5.46 2.82 1.11
Profit After Tax 3.55 9.32 5.15 9.79 4.8
Adjusted EPS (Rs) 0.09 0.18 0.1 0.18 0.09

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 57.14 112.88 66.58 120.29 176.5
Total Expenditure 51.59 100.33 50.88 87.74 130.36
Operating Profit 5.55 12.54 15.71 32.55 46.14
Other Income 0.39 0.24 0.11 0.17 0.25
Interest 4.21 3.93 4.18 4.06 4.35
Depreciation 1.84 1.87 1.89 1.77 1.36
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.11 6.99 9.75 26.89 40.68
Tax 0 1.17 0.09 6.37 12.87
Net Profit -0.11 5.82 9.66 20.52 27.81
Adjusted EPS (Rs.) -0.01 0.49 0.6 0.51 0.52

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 12 12 16 39.85 53.15
Total Reserves -10.45 -4.63 5.03 40.57 156.62
Borrowings 52.27 58.18 54.25 38.36 2.48
Other N/C liabilities 2.26 2.45 2.62 2.47 4.04
Current liabilities 28.89 43.55 50.1 60.05 100.91
Total Liabilities 84.97 111.55 128 181.3 317.21
Assets
Net Block 27.23 25.74 27.3 22.82 40.36
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 10.17
Loans & Advances 0 0 0 0 6.95
Other N/C Assets 0 0 0 0 0
Current Assets 57.74 85.81 100.7 158.48 259.73
Total Assets 84.97 111.55 128 181.3 317.21
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations -0.11 6.99 9.75 26.89 40.68
Adjustment 5.92 5.66 5.84 -0.56 5.51
Changes in Assets & Liabilities -7.57 -15.5 -18.8 -54.23 -85.01
Tax Paid 0 0 -0.01 5.35 -7.54
Operating Cash Flow -1.75 -2.85 -3.23 -22.55 -46.36
Investing Cash Flow -0.39 -0.33 -3.37 2.79 -27.96
Financing Cash Flow 2.81 2.27 8.25 18.94 76.29
Net Cash Flow 0.67 -0.92 1.65 -0.82 1.96

Corporate Actions

Investors Details

PARTICULARS Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 52.68 52.68 52.68 52.68
meet atulkumar vachhani - 17.70 17.70 17.70
punitkumar r rasadia - 34.98 34.98 34.98
meet atulkumar vachhani 17.70 - - -
punitkumar r rasadia 34.98 - - -
PARTICULARS Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 47.32 47.32 47.32 47.32
ban labs private limited 5.27 5.27 5.27 5.27
harshad rasiklal sheth - 1.32 1.13 1.13
jay mauleshkumar ukani - 1.13 1.13 1.13
luv natwarlal ukani - 1.13 1.13 1.13
shree dwarikadhish ventur... - 7.53 7.53 7.53
neomile growth fund - ser... - 4.40 4.54 -
samir ramesh parekh - 1.51 1.51 -
harshad rasiklal sheth 1.32 - - -
jay mauleshkumar ukani 1.13 - - -
luv natwarlal ukani 1.13 - - -
neomile corporate advisor... 7.92 - - -
neomile growth fund - ser... 2.52 - - -
samir ramesh parekh 1.51 - - -
shree dwarikadhish ventur... 7.53 - - -

Annual Reports

Title Link
Title Link
Annual Report 2025

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY26
Concall Q4FY26
Concall Q3FY26
Concall Q2FY26
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY26
Presentation Q3FY26

Company News

Anlon Healthcare informs about newspaper publication 17 Aug, 4:23 PM Anlon Healthcare - Quaterly Results 31 Jul, 12:00 AM Anlon Healthcare incorporates subsidiary company 13 Jul, 12:28 PM Anlon Healthcare informs about trading window closure 30 Jun, 2:55 PM Anlon Healthcare informs about invitation for tv interview 11 Jun, 12:15 PM Anlon Healthcare informs about conference call 9 Jun, 4:50 PM Anlon Healthcare informs about press release 30 May, 3:09 PM Anlon Healthcare informs about newspaper advertisement 30 May, 12:48 PM Anlon Healthcare informs about press release 30 May, 12:23 PM Anlon Healthcare informs about allotment of bonus equity shares 27 Apr, 11:19 AM Anlon Healthcare informs about share purchase agreement 16 Apr, 5:01 PM Anlon Healthcare surges on the BSE 16 Apr, 2:53 PM Anlon Healthcare to acquire 63.98% of equity share capital of Remember India Health Links 16 Apr, 2:29 PM Anlon Healthcare shines on acquiring 56.67% equity shareholding in Bizotic Life Science 20 Mar, 2:54 PM Anlon Healthcare acquires 56.67% equity shareholding in Bizotic Life Science 20 Mar, 2:18 PM Anlon Healthcare submits analyst meet intimation 18 Mar, 4:26 PM Anlon Healthcare informs about disclosure 12 Mar, 11:20 AM Anlon Healthcare informs about press release 11 Mar, 5:32 PM Anlon Healthcare - Quaterly Results 10 Feb, 12:00 AM Anlon Healthcare acquires 67.48% stake in Apiqo Organics 9 Jan, 3:51 PM Anlon Healthcare informs about updates 19 Dec, 5:18 PM Anlon Healthcare informs about newspaper advertisements 9 Dec, 3:19 PM Anlon Healthcare to acquire 67.48% shareholding in Apiqo Organics 2 Dec, 2:30 PM Anlon Healthcare to acquire 57% stake in Bizotic Lifescience 29 Nov, 2:42 PM Anlon Healthcare informs about investor presentation 19 Nov, 11:56 AM Anlon Healthcare - Quaterly Results 12 Nov, 12:00 AM Anlon Healthcare informs about disclosure 6 Nov, 4:35 PM Anlon Healthcare informs about compliance certificate 14 Oct, 5:11 PM Anlon Healthcare informs about investors meet 22 Sep, 5:05 PM Anlon Healthcare develops two new anti-malarial products 20 Sep, 6:01 PM Anlon Healthcare coming with IPO to raise upto Rs 121 crore 23 Aug, 3:14 PM

Anlon Healthcare Stock Price Analysis and Quick Research Report. Is Anlon Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Anlon Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Anlon Healthcare has a PE ratio of 28.5531370038412 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Anlon Healthcare has ROA of 11.1566% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Anlon Healthcare has a Current ratio of 2.5739.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Anlon Healthcare has a ROE of 19.1652%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Anlon Healthcare has a Debt to Equity ratio of 0.2174 which means that the company has low proportion of debt in its capital.

  • Sales growth: Anlon Healthcare has reported revenue growth of 46.7318% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Anlon Healthcare for the current financial year is 26.1405891374837%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Anlon Healthcare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Anlon Healthcare is Rs 0.5467. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Anlon Healthcare in Ticker for free. Also, one can get the intrinsic value of Anlon Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Anlon Healthcare FAQs

Q1. What is Anlon Healthcare share price today?
Ans: The current share price of Anlon Healthcare is Rs 15.61.

Q2. What is the market capitalisation of Anlon Healthcare?
Ans: Anlon Healthcare has a market capitalisation of Rs 829.694915 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Anlon Healthcare?
Ans: The PE ratio of Anlon Healthcare is 28.5531370038412 and the P/B ratio of Anlon Healthcare is 3.09912843217058, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Anlon Healthcare share?
Ans: The 52-week high share price of Anlon Healthcare is Rs 17.275, and the 52-week low share price of Anlon Healthcare is Rs 10.2.

Q5. Does Anlon Healthcare pay dividends?
Ans: Currently, Anlon Healthcare does not pay dividends. Dividend yield of Anlon Healthcare is around 0%.

Q6. What are the face value and book value of Anlon Healthcare shares?
Ans: The face value of Anlon Healthcare shares is Rs 2, while the book value per share of Anlon Healthcare is around Rs 5.0369. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Anlon Healthcare?
Ans: Anlon Healthcare has a total debt of Rs 45.5993 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Anlon Healthcare?
Ans: The ROE of Anlon Healthcare is 19.1652% and ROCE of Anlon Healthcare is 22.3829%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Anlon Healthcare a good buy for the long term?
Ans: The Anlon Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Anlon Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Anlon Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Anlon Healthcare’s financials?
Ans: You can review Anlon Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Anlon Healthcare
X